✦ LIBER ✦

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

✍ Scribed by J Braun; J Brandt; J Listing; A Zink; R Alten; W Golder; E Gromnica-lhle; H Kellner; A Krause; M Schneider; H Sörensen; H Zeidler; W Thriene; J Sieper

Book ID: 117280321
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 107 KB
Volume: 359
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)08215-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-blind, Placebo-controlled Trial

A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis

✍ INMAN, R. D.; MAKSYMOWYCH, W. P. 📂 Article 📅 2010 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 356 KB

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto

Maintenance of infliximab treatment in a

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

✍ Maxime Breban; Philippe Ravaud; Pascal Claudepierre; Gabriel Baron; Yves-Dominiq 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Efficacy and safety of infliximab in pat

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)

✍ Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeW 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Anti-interleukin-17A monoclonal antibody

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

✍ Baeten, Dominique; Baraliakos, Xenofon; Braun, Jürgen; Sieper, Joachim; Emery, P 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 780 KB

Successful treatment of active ankylosin

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

✍ Jan Brandt; Hildrun Haibel; Daniel Cornely; Werner Golder; José Gonzalez; Jaquel 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB